Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Rizzo

Showing results (241-250 of 381) with videos related to

Pageof 39
Sort By:
Medicines (Basel, Switzerland)|September 4, 2020
PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block?Angela Dalia Ricci, Alessandro Rizzo, Chiara Bonucci, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Intensive Follow-Up Program and Oncological Outcomes of Biliary Tract Cancer Patients after Curative-Intent Surgery: A Twenty-Year Experience in a Single Tertiary Medical CenterAlessandro Rizzo, Riccardo Carloni, Giorgio Frega, et al.
Cancer Control : Journal of the Moffitt Cancer Center|December 28, 2020
Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future ChallengesAlessandro Rizzo, Alessandro Di Federico, Angela Dalia Ricci, et al.
Frontiers in Nutrition|May 1, 2023
Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research groupLuigi Marano, Federica Marmorino, Isacco Desideri, et al.
Frontiers in Oncology|August 2, 2024
The role of immune checkpoint inhibitors in the first-line treatment for patients with advanced biliary tract cancer: a systematic review and meta-analysis of randomized trialsElsa Vitale, Alessandro Rizzo, Lorenza Maistrello, et al.
International Journal of Molecular Sciences|July 2, 2021
The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What's the Story Morning Glory?Andrea Marchetti, Matteo Rosellini, Veronica Mollica, et al.
Translational Andrology and Urology|April 14, 2021
Adjuvant therapy in renal cell carcinoma: is it the right strategy to inhibit VEGF?Veronica Mollica, Alessandro Rizzo, Vincenzo Di Nunno, et al.
International Journal of Molecular Sciences|April 30, 2021
Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational ImplicationsKarim Rihawi, Angela Dalia Ricci, Alessandro Rizzo, et al.
Future Medicinal Chemistry|August 23, 2022
Advances in novel systemic therapies for advanced hepatocellular carcinomaRiccardo Carloni, Alessandro Rizzo, Antonio Cusmai, et al.
Pathology, Research and Practice|February 8, 2021
Broad spectrum mutational analysis of chromophobe renal cell carcinoma using next-generation sequencingVeronica Mollica, Tania Franceschini, Elisa Gruppioni, et al.
Pageof 39

Showing results (241-250 of 381) with videos related to

Sort By:
Pageof 39
Medicines (Basel, Switzerland)|September 4, 2020
PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block?Angela Dalia Ricci, Alessandro Rizzo, Chiara Bonucci, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Intensive Follow-Up Program and Oncological Outcomes of Biliary Tract Cancer Patients after Curative-Intent Surgery: A Twenty-Year Experience in a Single Tertiary Medical CenterAlessandro Rizzo, Riccardo Carloni, Giorgio Frega, et al.
Cancer Control : Journal of the Moffitt Cancer Center|December 28, 2020
Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future ChallengesAlessandro Rizzo, Alessandro Di Federico, Angela Dalia Ricci, et al.
Frontiers in Nutrition|May 1, 2023
Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research groupLuigi Marano, Federica Marmorino, Isacco Desideri, et al.
Frontiers in Oncology|August 2, 2024
The role of immune checkpoint inhibitors in the first-line treatment for patients with advanced biliary tract cancer: a systematic review and meta-analysis of randomized trialsElsa Vitale, Alessandro Rizzo, Lorenza Maistrello, et al.
International Journal of Molecular Sciences|July 2, 2021
The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What's the Story Morning Glory?Andrea Marchetti, Matteo Rosellini, Veronica Mollica, et al.
Translational Andrology and Urology|April 14, 2021
Adjuvant therapy in renal cell carcinoma: is it the right strategy to inhibit VEGF?Veronica Mollica, Alessandro Rizzo, Vincenzo Di Nunno, et al.
International Journal of Molecular Sciences|April 30, 2021
Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational ImplicationsKarim Rihawi, Angela Dalia Ricci, Alessandro Rizzo, et al.
Future Medicinal Chemistry|August 23, 2022
Advances in novel systemic therapies for advanced hepatocellular carcinomaRiccardo Carloni, Alessandro Rizzo, Antonio Cusmai, et al.
Pathology, Research and Practice|February 8, 2021
Broad spectrum mutational analysis of chromophobe renal cell carcinoma using next-generation sequencingVeronica Mollica, Tania Franceschini, Elisa Gruppioni, et al.
Pageof 39